2022 China Integrated Vascular Access Forum (CIVA) Successfully Concludes in Shanghai

ShanghaiAugust 8, 2022PR Newswire -- With the continuous improvement of medical technology and the optimization and updating of academic concepts in the field of vascular access in China, topics such as infection prevention and control in medical institutions, the role of imaging technology in vascular access diagnosis and treatment, and multidisciplinary cross-departmental diagnosis and treatment have become hot academic issues. The original intention of the China Vascular Access Summit (CIVA) is to build an academic exchange platform for experts and scholars in the industry to showcase research results and listen to cutting-edge voices. While promoting offline exchanges, it will also share viewpoints online with peers across China, enhancing the management level of vascular access in China and bringing health benefits to patients.

Launch Ceremony / Venue View

On August 6, the "China Vascular Access Summit Forum (CIVA)," hosted by the China Health Promotion and Education Association and supported by BD Medical, was held in Shanghai. Authoritative experts and scholars in the field of vascular access gathered both on-site and through cloud connections to exchange frontline clinical experiences, analyze the latest guidelines and consensus, and discuss cutting-edge appropriate technologies. The event attracted nearly 200,000 participants, including medical staff from 4,389 hospitals attending both online and offline. The China Vascular Access Summit Forum (CIVA) was established in 2019 with the aim of building a top-tier academic exchange platform, playing an active role in sharing achievements, promoting technology, and passing on experience.For China's leading vascularA place where academic concepts in the field of pathways intersect, promoting the optimization and enhancement of vascular access management in China.

Ms. Kong Lingzhi, Standing Vice President and Secretary General of the China Health Promotion and Education Association, stated in her speech that this forum explores the academic frontier in the field of vascular access through multidisciplinary professional integration. It addresses the issues and countermeasures faced in the development of vascular access management, providing a platform for medical professionals to exchange, share, and progress together. This initiative aims to promote the professional development of vascular access and enhance the professional capabilities of healthcare providers in this field, ultimately ensuring safe, systematic, and precise vascular access for patients.

Venue Screen

This high-level forum is divided into four major sections: Expert Perspectives, Cross-Departmental Collaboration, Key Highlights, and Imaging Empowerment. Among these, Key Highlights is a brand-new section introduced in this edition. Experts from the fields of intravenous therapy, oncology, hematology, critical care, and infection control are involved.'s LectureThe article comprehensively interprets the latest research progress, technological trends, and practical experiences in the field of vascular access, including infection control and management in hospitals during the pandemic, and how to achieve high-quality development of oncology specialties under the DRG model.、The construction and management of the tumor static therapy MDT team, the development and implementation of imaging department vascular access planning schemes, and other topics are closely aligned with industry hotspots, offering a wealth of exciting content.

Speech Screen/Roundtable Forum

Nowadays, China has accumulated rich practical experience and evidence-based medical foundations in the field of vascular access, forming several consensuses that not only guide the clinical management of vascular access domestically but also influence the future development of the global vascular access field. For this reason, this forum has set up roundtable discussions in two sections: Expert Perspectives and Key Insights. Multiple authoritative experts, based on major guidelines, conducted in-depth discussions on how to reduce catheter-related bloodstream infections and the evidence and practice of vascular access management for critically ill patients both domestically and internationally.

BD Greater China Vice President of Medication Delivery Solutions, Lv Wen, stated that high-quality medical services are essential for achieving public health. The advancement of modern medical technology and the evolution of healthcare concepts are crucial pathways for healthcare professionals to deliver quality care. Intravenous therapy is no longer just a simple basic procedure as traditionally perceived; instead, it involves multidisciplinary and multi-level knowledge and skills related to vascular access. As a global medical technology company, BD will continue to honor its firm commitment to healthcare professionals and patients in China, further contributing to the development of the vascular access field in the country, and helping elevate vascular access practices in China to a higher level.